Night Squared LP Has $6.17 Million Position in Xylem Inc. $XYL

Night Squared LP increased its position in Xylem Inc. (NYSE:XYL) by 12.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 45,325 shares of the industrial products company’s stock after purchasing an additional 5,080 shares during the quarter. Xylem makes up 1.7% of Night Squared LP’s holdings, making the stock its 29th largest position. Night Squared LP’s holdings in Xylem were worth $6,172,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of XYL. AQR Capital Management LLC raised its holdings in shares of Xylem by 14.4% in the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after purchasing an additional 3,900 shares during the period. NewEdge Advisors LLC raised its holdings in shares of Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after purchasing an additional 132 shares during the period. Empowered Funds LLC raised its holdings in shares of Xylem by 56.1% in the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the period. Arrowstreet Capital Limited Partnership raised its holdings in shares of Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after purchasing an additional 5,509 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Xylem by 114.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after purchasing an additional 635 shares during the period. 87.96% of the stock is owned by institutional investors.

Xylem Stock Performance

Shares of XYL stock opened at $112.19 on Wednesday. The company has a market capitalization of $26.67 billion, a price-to-earnings ratio of 27.91, a PEG ratio of 1.58 and a beta of 1.04. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. The company has a 50-day simple moving average of $115.39 and a 200 day simple moving average of $126.83. Xylem Inc. has a 52 week low of $105.29 and a 52 week high of $154.27.

Xylem (NYSE:XYL) last announced its earnings results on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.13 billion during the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. Xylem’s revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.03 EPS. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts predict that Xylem Inc. will post 5.51 earnings per share for the current year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s payout ratio is currently 42.79%.

Xylem announced that its board has initiated a share buyback plan on Wednesday, February 25th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the industrial products company to buy up to 4.8% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s leadership believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on XYL shares. Jefferies Financial Group reaffirmed a “hold” rating and issued a $130.00 target price (down from $140.00) on shares of Xylem in a report on Tuesday, March 31st. Barclays dropped their target price on shares of Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a report on Wednesday, April 29th. JPMorgan Chase & Co. reduced their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a report on Thursday, April 16th. Citigroup reduced their target price on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Finally, Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, May 8th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $152.77.

Insider Transactions at Xylem

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at $423,443.30. The trade was a 54.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the business’s stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $116.61 per share, with a total value of $141,098.10. Following the acquisition, the director directly owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.32% of the company’s stock.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.